Cumberland Pharmaceuticals (CPIX) EBT (2010 - 2026)

Cumberland Pharmaceuticals has disclosed EBT across 17 years of filings, most recently posting -$3.1 million for Q2 2026.

• In Q2 2026, EBT fell 3.6% year-over-year to -$3.1 million; the TTM figure through Jun 2026 stood at -$9.6 million (down 83.29% YoY), while the FY2025 annual figure was -$2.8 million, up 56.53% from the prior year.
• EBT came in at -$3.1 million for Q2 2026 at Cumberland Pharmaceuticals, up from -$3.1 million in the prior quarter.
• In the past five years, EBT ranged from a high of $1.3 million in Q1 2025 to a low of -$6.3 million in Q4 2023.
• Average EBT over 5 years is -$1.6 million, with a median of -$1.5 million recorded in 2022.
• Year-over-year, EBT plunged 1155.12% in 2024 and soared 166.31% in 2025.
• Over 5 years, EBT stood at -$2.4 million in 2022, then tumbled by 160.29% to -$6.3 million in 2023, then surged by 68.8% to -$2.0 million in 2024, then advanced by 28.92% to -$1.4 million in 2025, then plunged by 122.69% to -$3.1 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$3.1 million in Q2 2026, -$3.1 million in Q1 2026, and -$1.4 million in Q4 2025.